Mario Gabelli health update and leadership roles at Gabelli Global (NYSE: GGZ)

Rhea-AI Filing Summary

The Gabelli Global Small and Mid Cap Value Trust reported a health update and leadership arrangements involving its longtime portfolio leader, Mario J. Gabelli. He was hospitalized for observation and testing after a medical incident on March 19, 2026, and his condition is described as improving, though his return date is not yet known.

GAMCO Investors, Inc. activated its longstanding succession plan on March 22, 2026, naming Christopher J. Marangi as President of GAMCO. Day-to-day operations at GAMCO are being led by co-CEO Douglas R. Jamieson and Mr. Marangi, while the Fund’s portfolio is being managed by Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Mr. Marangi. The Fund also states that this information is incorporated by reference into its effective registration statement.

Insights

Closed-end fund governance analyst

Fund discloses Mario Gabelli’s medical leave and confirms an existing succession plan is in effect.

The Gabelli Global Small and Mid Cap Value Trust highlights that Mario J. Gabelli is recovering from a March 19, 2026 medical incident and that his return timeline is undetermined. This is important because he has been a central investment figure associated with the Fund and its adviser.

The filing emphasizes continuity. GAMCO implemented a pre-existing succession plan on March 22, 2026, appointing Christopher J. Marangi as President. Operational leadership at GAMCO rests with co-CEO Douglas R. Jamieson and Mr. Marangi, while portfolio management for the Fund is led by Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Mr. Marangi.

The disclosure reassures that investment and business functions are covered by an established team rather than ad hoc arrangements. The information is also incorporated into the Fund’s effective registration statement, formally aligning these leadership details with current offering documents and providing clarity for investors reviewing the Fund’s governance and management structure.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Key Figures

Medical incident date: March 19, 2026 Succession plan activation date: March 22, 2026 8-K report date: May 7, 2026

3 metrics

Medical incident date March 19, 2026 Date of Mario J. Gabelli medical incident

Succession plan activation date March 22, 2026 Date GAMCO implemented its succession plan

8-K report date May 7, 2026 Date of the current report by the Fund

Key Terms

succession plan, emerging growth company, Registration Statement, Co-Chief Investment Officers

4 terms

succession plan financial

"On March 22, 2026, GAMCO ... implemented GAMCO’s succession plan that has been in place for several years."

emerging growth company regulatory

"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ... Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Registration Statement regulatory

"The Fund incorporates the information included in this Item 8.01 by reference into its effective Registration Statement."

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

Co-Chief Investment Officers financial

"The Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi lead the portfolio management team"

Understanding 8-K Material Events →

false 0001585855 0001585855 2026-05-07 2026-05-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) May 7, 2026

The Gabelli Global Small and Mid Cap Value Trust

(Exact name of registrant as specified in its charter)

Delaware		811-22884		46-4510162
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

One Corporate Center, Rye, New York		10580
(Address of principal executive offices)		(Zip Code)

Registrants telephone number, including area code (800) 422-3554

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Shares of Beneficial Interest		GGZ		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events

As previously announced by GAMCO Investors, Inc. (“GAMCO”) on March 23, 2026, Mario J. Gabelli (“Mr. Gabelli”), Trustee, Chairman and Chief Investment Officer of the Fund, and Chairman, Co-Chief Executive Officer, and Chief Investment Officer – Value Portfolios of GAMCO Investors, Inc. and Chief Investment Officer – Value Portfolios of Gabelli Funds, LLC and GAMCO Asset Management, Inc., was admitted to the hospital for observation and testing after a medical incident March 19, 2026, following a busy day of events around New York City. His condition is improving and he is on the road to recovery, but the timeline for his return is not yet known.

On March 22, 2026, GAMCO, the parent company of the Fund’s adviser, Gabelli Funds, LLC (the “Adviser”), implemented GAMCO’s succession plan that has been in place for several years. In accordance with that plan, Christopher J. Marangi was named President of GAMCO on March 22, 2026.

While the timeline for Mr. Gabelli’s return remains undetermined, the day-to-day operations of GAMCO will continue to be led by co-CEO, Douglas R. Jamieson, and Christopher J. Marangi.

The Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi lead the portfolio management team for the Fund during Mr. Gabelli’s absence.

The Fund incorporates the information included in this Item 8.01 by reference into its effective Registration Statement.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	THE GABELLI GLOBAL SMALL AND MID CAP VALUE TRUST
Date: May 7, 2026	By:	/s/ John C. Ball
	Name:	John C. Ball
	Title:	President and Treasurer

2

FAQ

What did The Gabelli Global Small and Mid Cap Value Trust (GGZ) disclose about Mario J. Gabelli?

The Fund disclosed that Mario J. Gabelli experienced a medical incident on March 19, 2026 and was hospitalized for observation and testing. His condition is improving and he is described as being on the road to recovery, though the timing of his return is not yet known.

How is leadership at GAMCO and the adviser structured during Mario Gabelli’s absence for GGZ?

During Mario Gabelli’s absence, GAMCO’s day-to-day operations are led by co-CEO Douglas R. Jamieson and Christopher J. Marangi. For the Fund’s portfolio, Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi lead the management responsibilities according to the succession plan.

What succession actions did GAMCO take that affect The Gabelli Global Small and Mid Cap Value Trust (GGZ)?

On March 22, 2026, GAMCO implemented its longstanding succession plan and named Christopher J. Marangi as President of GAMCO. This action clarifies who holds senior leadership responsibilities at the adviser’s parent company while Mario J. Gabelli recovers from his medical incident.

Does the GGZ filing say whether Mario Gabelli’s return date has been set?

The filing states that Mario J. Gabelli’s condition is improving and he is on the road to recovery, but that the timeline for his return is not yet known. This acknowledges uncertainty around his exact resumption of duties while confirming his current health trajectory.

Who currently leads portfolio management for The Gabelli Global Small and Mid Cap Value Trust (GGZ)?

Portfolio management for the Fund is led by Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi. They are identified as heading the portfolio management team during Mario J. Gabelli’s absence, reflecting the adviser’s team-based investment leadership approach.

How is this leadership information used in relation to GGZ’s registration statement?

The Fund states that the information about Mario Gabelli’s medical status and the related leadership roles is incorporated by reference into its effective registration statement. This ensures offering documents reflect current management arrangements for investors reviewing GGZ’s disclosures and governance details.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL PRESENTATION FILE 21.8 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL SCHEMA FILE 3.0 KB